EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis

Fahimeh Akbarian iD, Chiara Rossi, Lars Costers, Marie B D'hooghe, Miguel D'haeseleer, Guy Nagels, Jeroen Van Schependom

Human Brain Mapping · 2023

DOI: 10.1002/hbm.26476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Brain Mapping, 2023. Verfasst von Fahimeh Akbarian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Brussels, Belgium. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vrije Universiteit Brussel, Innoviris, Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a neurodegenerative disease characterized by neuronal and synaptic loss, resulting in an imbalance of excitatory and inhibitory synaptic transmission and potentially cognitive impairment. Current methods for measuring the excitation/inhibition (E/I) ratio are mostly invasive, but recent research combining neurocomputational modeling with measurements of local field potentials has indicated that the slope with which the power spectrum of neuronal activity captured by electro‐ and/or magnetoencephalography rolls off, is a non‐invasive biomarker of the E/I ratio. A steeper roll‐off is associated with a stronger inhibition. This novel method can be applied to assess the E/I ratio in people with multiple sclerosis (pwMS), detect the effect of medication such as benzodiazepines, and explore its utility as a biomarker for cognition. We recruited 44 healthy control subjects and 95 pwMS who underwent resting‐state magnetoencephalographic recordings. The 1/f spectral slope of the neural power spectra was calculated for each subject and for each brain region. As expected, the spectral slope was significantly steeper in pwMS treated with benzodiazepines (BZDs) compared to pwMS not receiving BZDs ( p = .01). In the sub‐cohort of pwMS not treated with BZDs, we observed a steeper slope in cognitively impaired pwMS compared to cognitively preserved pwMS ( p = .01) and healthy subjects ( p = .02). Furthermore, we observed a significant correlation between 1/f spectral slope and verbal and spatial working memory functioning in the brain regions located in the prefrontal and parietal cortex. In this study, we highlighted the value of the spectral slope in MS by quantifying the effect of benzodiazepines and by putting it forward as a potential biomarker of cognitive deficits in pwMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisNeurodegenerative DiseasesHumansCognitionBenzodiazepinesBiomarkers

Stichwörter der Autor:innen

1/f spectral slopeaperiodicaperiodic exponentexcitation/inhibition balancemagnetoencephalographyresting statespectral power

Substanzen

BenzodiazepinesBiomarkers

Autor:innen und Institutionen

  • Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Brussels, Belgium.
  • AIMS Lab, Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.
  • icometrix, Leuven, Belgium.
  • National MS Center Melsbroek, Melsbroek, Belgium.
  • Department of Neurology, UZ Brussel, Brussels, Belgium.
  • St Edmund Hall, University of Oxford, Oxford, UK.

ORCID-Profile: Fahimeh Akbarian

Förderung

  • Vrije Universiteit Brussel
  • Innoviris
  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Akbarian, F., Rossi, C., Costers, L., D'hooghe, M. B., D'haeseleer, M., Nagels, G., & Van Schependom, J. (2023). The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis. Human Brain Mapping. https://doi.org/10.1002/hbm.26476

Vancouver

Akbarian F, Rossi C, Costers L, D'hooghe MB, D'haeseleer M, Nagels G, et al. The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis. Human Brain Mapping. 2023. doi:10.1002/hbm.26476

BibTeX
@article{Akbarian2023,
  author = {Akbarian, Fahimeh and Rossi, Chiara and Costers, Lars and D'hooghe, Marie B and D'haeseleer, Miguel and Nagels, Guy and Van Schependom, Jeroen},
  title = {The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis},
  journal = {Human Brain Mapping},
  year = {2023},
  doi = {10.1002/hbm.26476}
}
Kostenlos starten →